Fluoresentric, Inc.
- UEI
- Y2KPHNXA9MF5
- CAGE
- 414S2
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Fluoresentric, Inc.
Y2KPHNXA9MF5
- XCR Diagnostics, Inc. RQDPRJPLWHA8
-
Fluoresentric, Inc.
Y2KPHNXA9MF5
- SAM.gov registration date
- Website
- fluoresentric.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| For other functions | CDC Pittsburgh | $207,900 | |
| Cbot singlepex assays | CDC Office of Acquisition Services | $207,900 | |
| Laboratory supplies | CDC Office of Acquisition Services | $41,500 | |
| Lab supplies - assay | CDC Office of Acquisition Services | $124,500 | |
| Cbot a singleplex assays | CDC Office of Acquisition Services | $124,500 |
About Fluoresentric, Inc.
Fluoresentric, Inc. is a manufacturer of goods registered to receive awards from the U.S. federal government since July 18, 2005. The company, structured as a corporate entity, specializes in producing molecular diagnostic testing products and laboratory supplies. Fluoresentric operates as a parent company, with XCR Diagnostics, Inc. functioning as its subsidiary. Together, they have secured multiple federal contract awards, primarily from the Centers for Disease Control and Prevention (CDC), to provide critical laboratory reagents and diagnostic testing materials. These products support the CDC's mission to protect public health through disease control and prevention efforts.
The federal contract awards to Fluoresentric and its subsidiary XCR Diagnostics have consistently been for the provision of laboratory supplies, particularly CBOT singleplex assays and related reagents. These purchase orders, ranging from $151,410 to $211,771, have been awarded by the CDC's Pittsburgh office between 2020 and 2023. The contracts are typically firm fixed price agreements with short performance periods, usually spanning a few months. Notable is the absence of set-aside designations in these awards, indicating that Fluoresentric competes in the open market. The company has demonstrated a consistent ability to secure contracts for specialized diagnostic products, suggesting a strong reputation in the field of molecular diagnostics. These awards directly support the CDC's diagnostic testing capabilities, playing a crucial role in the agency's efforts to identify and respond to various diseases and health threats.
Quick answers
What is Fluoresentric, Inc.'s UEI?
Fluoresentric, Inc.'s Unique Entity ID (UEI) in SAM.gov is Y2KPHNXA9MF5.
What is Fluoresentric, Inc.'s CAGE code?
Fluoresentric, Inc.'s CAGE code is 414S2.
What is Fluoresentric, Inc.'s primary NAICS code?
Fluoresentric, Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).
Is Fluoresentric, Inc. registered in SAM.gov?
Fluoresentric, Inc.'s SAM.gov registration expired on August 14, 2019.
What is Fluoresentric, Inc.'s most recent federal award?
Fluoresentric, Inc.'s most recent federal contract award is For other functions (HHSD2002017M94674P), from CDC Pittsburgh, on July 10, 2017.
On GovTribe
See Fluoresentric, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors